English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessPfizer, BioNTech to supply 120 million doses of coronavirus vaccine to Japan

    Pfizer, BioNTech to supply 120 million doses of coronavirus vaccine to Japan

    The companies said, assuming success of the vaccine in clinical studies, they are on track to seek regulatory review for the vaccine as early as October.

    Reuters
    July 31, 2020 / 16:07 IST

    Pfizer Inc and BioNTech SE have agreed to supply Japan with 120 million doses of their mRNA-based vaccine candidate against the novel coronavirus in the first half of 2021, the companies said on Friday.

    The companies said, assuming success of the vaccine in clinical studies, they are on track to seek regulatory review for the vaccine as early as October.

    The companies did not disclose the financial details of the agreement.

    Follow our full coverage of the coronavirus pandemic here.

    Reuters
    first published: Jul 31, 2020 03:55 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347